Sequential chemoradiotherapy followed by sugemalimab for locally advanced NSCLC. Bi N, Wang Y, Wang L. Lancet Oncol 2022;23:e158.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Bi N, Wang Y, Wang L. Sequential chemoradiotherapy followed by sugemalimab for locally advanced NSCLC. Lancet Oncol 2022;23:e158.
PMID: 35358458